These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Assay of 4CMB, 4HMB and BC by the micronucleus tests--subcutaneous administration. Scott K, Topham JC. Mutat Res; 1982; 100(1-4):365-71. PubMed ID: 7057774 [No Abstract] [Full Text] [Related]
30. Dermal carcinogenesis bioassays of diesel particulates and dichloromethane extract of diesel particulates in C3H mice. Depass LR, Chen KC, Peterson LG. Dev Toxicol Environ Sci; 1982; 10():321-7. PubMed ID: 6176430 [No Abstract] [Full Text] [Related]
31. Antibody stimulation of benzo(a)pyrene carcinogenesis. Curtis GL, Ryan WL, Stenbäck F. Cancer Lett; 1978 Apr; 4(4):223-8. PubMed ID: 647663 [Abstract] [Full Text] [Related]
32. Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Higginbotham S, RamaKrishna NV, Johansson SL, Rogan EG, Cavalieri EL. Carcinogenesis; 1993 May; 14(5):875-8. PubMed ID: 8504480 [Abstract] [Full Text] [Related]
33. Accelerated development of benzo(alpha)pyrene-induced skin tumors in mice treated with pyran copolymer. Kripke ML, Borsos T. J Natl Cancer Inst; 1974 Nov; 53(5):1409-10. PubMed ID: 4431058 [No Abstract] [Full Text] [Related]
34. Comparative dose-response tumorigenicity studies of dibenzo[alpha,l]pyrene versus 7,12-dimethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Cavalieri EL, Higginbotham S, RamaKrishna NV, Devanesan PD, Todorovic R, Rogan EG, Salmasi S. Carcinogenesis; 1991 Oct; 12(10):1939-44. PubMed ID: 1934274 [Abstract] [Full Text] [Related]
35. Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse. Chang RL, Huang MT, Wood AW, Wong CQ, Newmark HL, Yagi H, Sayer JM, Jerina DM, Conney AH. Carcinogenesis; 1985 Aug; 6(8):1127-33. PubMed ID: 3926336 [Abstract] [Full Text] [Related]
36. Carcinogenicity of 2-hydroxybenzo(a)pyrene and 6-hydroxybenzo(a)pyrene in newborn mice. Chang RL, Wislocki PG, Kapitulnik J, Wood AW, Levin W, Yagi H, Mah HD, Jerina DM, Conney AH. Cancer Res; 1979 Jul; 39(7 Pt 1):2660-4. PubMed ID: 376121 [Abstract] [Full Text] [Related]
37. Bacterial mutagenicity tests on 4-chloromethylbiphenyl and 2 structural analogues. Kirkland DJ, Smith KL, Parmar V. Mutat Res; 1982 Jul; 100(1-4):21-5. PubMed ID: 7035892 [Abstract] [Full Text] [Related]
38. 4-Chloromethylbiphenyl (4CMB): a novel mutagen and potential carcinogen. Ashby J, Trueman RW, Styles J, Penman MG, Paton D. Carcinogenesis; 1981 Jul; 2(1):33-8. PubMed ID: 7023721 [Abstract] [Full Text] [Related]
39. Comparison of the tumor-initiating activity of 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene in female SENCAR and CS-1 mice. DiGiovanni J, Slaga TJ, Boutwell RK. Carcinogenesis; 1980 May; 1(5):381-9. PubMed ID: 6268318 [No Abstract] [Full Text] [Related]
40. [Experimental studies of the carcinogenicity and the retention of benzo(a)pyrene in application region after intratracheal and subcutaneous injection (author's transl)]. Pott F, Tomingas R, Reiffer FJ. Zentralbl Bakteriol Orig B; 1973 Oct; 158(2):97-108. PubMed ID: 4779177 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]